NZ209055A - Veterinary compositions containing dithia derivatives - Google Patents
Veterinary compositions containing dithia derivativesInfo
- Publication number
- NZ209055A NZ209055A NZ209055A NZ20905584A NZ209055A NZ 209055 A NZ209055 A NZ 209055A NZ 209055 A NZ209055 A NZ 209055A NZ 20905584 A NZ20905584 A NZ 20905584A NZ 209055 A NZ209055 A NZ 209055A
- Authority
- NZ
- New Zealand
- Prior art keywords
- dithia
- ketosis
- formula
- cows
- livestock
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title description 4
- 208000007976 Ketosis Diseases 0.000 claims abstract description 30
- 230000004140 ketosis Effects 0.000 claims abstract description 29
- 244000144972 livestock Species 0.000 claims abstract description 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 9
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 6
- 230000037396 body weight Effects 0.000 claims description 5
- 235000019260 propionic acid Nutrition 0.000 claims description 4
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- YPIQVCUJEKAZCP-UHFFFAOYSA-N Malotilate Chemical group CC(C)OC(=O)C(C(=O)OC(C)C)=C1SC=CS1 YPIQVCUJEKAZCP-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- UFHLMYOGRXOCSL-UHFFFAOYSA-N isoprothiolane Chemical group CC(C)OC(=O)C(C(=O)OC(C)C)=C1SCCS1 UFHLMYOGRXOCSL-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 5
- 125000000217 alkyl group Chemical group 0.000 abstract description 2
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 241000283690 Bos taurus Species 0.000 description 27
- 210000004369 blood Anatomy 0.000 description 17
- 150000002576 ketones Chemical class 0.000 description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 210000002700 urine Anatomy 0.000 description 8
- WDJHALXBUFZDSR-UHFFFAOYSA-N Acetoacetic acid Natural products CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 6
- WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 description 6
- 235000021588 free fatty acids Nutrition 0.000 description 6
- 235000019789 appetite Nutrition 0.000 description 5
- 230000036528 appetite Effects 0.000 description 5
- 235000013365 dairy product Nutrition 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 229920002527 Glycogen Polymers 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 229940096919 glycogen Drugs 0.000 description 4
- 230000006651 lactation Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000004767 rumen Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 208000019423 liver disease Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 206010008635 Cholestasis Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000006180 nutrition needs Nutrition 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical compound OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- MCJXIAUNRSQHBP-UHFFFAOYSA-N 2-[2,3-di(propan-2-yl)-1h-inden-1-yl]-1,3-dithiolane;propanedioic acid Chemical compound OC(=O)CC(O)=O.CC(C)C1=C(C(C)C)C2=CC=CC=C2C1C1SCCS1 MCJXIAUNRSQHBP-UHFFFAOYSA-N 0.000 description 1
- 206010000410 Acetonaemia Diseases 0.000 description 1
- -1 B^ or the like Chemical class 0.000 description 1
- 206010056375 Bile duct obstruction Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 241001662043 Icterus Species 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 231100000359 cholestasis Toxicity 0.000 description 1
- 230000007870 cholestasis Effects 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 235000012888 dietary physiology Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- CQQJGTPWCKCEOQ-UHFFFAOYSA-L magnesium dipropionate Chemical compound [Mg+2].CCC([O-])=O.CCC([O-])=O CQQJGTPWCKCEOQ-UHFFFAOYSA-L 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 125000004436 sodium atom Chemical group 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 1
- 239000004324 sodium propionate Substances 0.000 description 1
- 235000010334 sodium propionate Nutrition 0.000 description 1
- 229960003212 sodium propionate Drugs 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Feed For Specific Animals (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58139488A JPS6051110A (ja) | 1983-08-01 | 1983-08-01 | 家畜のケト−ジス治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ209055A true NZ209055A (en) | 1987-08-31 |
Family
ID=15246420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ209055A NZ209055A (en) | 1983-08-01 | 1984-07-30 | Veterinary compositions containing dithia derivatives |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5001143A (https=) |
| EP (1) | EP0134112B1 (https=) |
| JP (1) | JPS6051110A (https=) |
| AT (1) | ATE62131T1 (https=) |
| AU (1) | AU564799B2 (https=) |
| DE (1) | DE3484375D1 (https=) |
| NZ (1) | NZ209055A (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62158215A (ja) * | 1985-12-28 | 1987-07-14 | Nippon Nohyaku Co Ltd | 脂肪壊死症治療剤 |
| GB2188842A (en) * | 1986-02-05 | 1987-10-14 | Zyma Sa | Cyclic dithiols for treating pulmonary fibrosis |
| JPS6364071A (ja) * | 1986-09-05 | 1988-03-22 | Mita Ind Co Ltd | 電子写真複写機の加熱定着装置 |
| US5244096A (en) * | 1988-04-22 | 1993-09-14 | Stoner Fred L | Preventive treatment kit against sexually transmitted disease |
| GB9418420D0 (en) * | 1994-09-13 | 1994-11-02 | Mckeown Neil A | Composition for the treatment of an energy imbalance in ruminents |
| US6126986A (en) * | 1999-02-23 | 2000-10-03 | Westway Trading Corporation | Process for formulating a liquid animal feed ingredient containing sugar and neutralized carboxylic acid |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE332310C (de) * | 1918-03-12 | 1921-01-26 | Hermann Deigmoeller | Verbrennungskraftmaschine |
| US4004151A (en) * | 1975-05-21 | 1977-01-18 | Novak William P | Detector for deep well logging |
| US4118506A (en) * | 1975-06-06 | 1978-10-03 | Nihon Nohyaku Co., Ltd. | Pharmaceutical compositions containing 1,3-dithiol-2-ylidene malonate derivatives |
| ZA763077B (en) * | 1975-06-06 | 1977-04-27 | Nihon Nohyaku Co Ltd | Pharmaceutical composition cor curing liver diseases |
| US4080466A (en) * | 1975-06-06 | 1978-03-21 | Nihon Nohyaku Co., Ltd. | Pharmaceutical compositions containing 4-hydroxyl-1,3-dithiolan-2-ylidene malonates |
| US4022907A (en) * | 1975-06-06 | 1977-05-10 | Nihon Nohyaku Co. Ltd. | Pharmaceutical compositions containing 1,3-dithiacycloalkylidene malonates |
| JPS51144735A (en) * | 1975-06-06 | 1976-12-13 | Nippon Nohyaku Co Ltd | A remedy for hepatic failure |
| US4080467A (en) * | 1975-06-06 | 1978-03-21 | Nihon Nohyaku Co., Ltd. | Pharmaceutical compositions comprising 1,3-dithiolan-2-ylidene malonate derivatives |
| JPS5750916A (en) * | 1980-09-12 | 1982-03-25 | Nippon Nohyaku Co Ltd | Carcinostatic agent |
| NO831160L (no) * | 1982-04-08 | 1983-10-10 | Erba Farmitalia | Fremstilling av substituerte penem-derivater |
| JPS591478A (ja) * | 1982-06-28 | 1984-01-06 | Nippon Nohyaku Co Ltd | ４，５―ジヒドロキシ―１，３―ジチオラン―２―イリデンマロン酸誘導体 |
-
1983
- 1983-08-01 JP JP58139488A patent/JPS6051110A/ja active Granted
-
1984
- 1984-07-30 AU AU31305/84A patent/AU564799B2/en not_active Ceased
- 1984-07-30 NZ NZ209055A patent/NZ209055A/en unknown
- 1984-07-31 DE DE8484305210T patent/DE3484375D1/de not_active Expired - Lifetime
- 1984-07-31 AT AT84305210T patent/ATE62131T1/de not_active IP Right Cessation
- 1984-07-31 EP EP84305210A patent/EP0134112B1/en not_active Expired - Lifetime
-
1989
- 1989-08-28 US US07/399,447 patent/US5001143A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US5001143A (en) | 1991-03-19 |
| JPH0532367B2 (https=) | 1993-05-14 |
| JPS6051110A (ja) | 1985-03-22 |
| ATE62131T1 (de) | 1991-04-15 |
| AU564799B2 (en) | 1987-08-27 |
| AU3130584A (en) | 1985-02-07 |
| DE3484375D1 (de) | 1991-05-08 |
| EP0134112B1 (en) | 1991-04-03 |
| EP0134112A3 (en) | 1985-12-18 |
| EP0134112A2 (en) | 1985-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Li et al. | Amino acid nutrition and metabolism in domestic cats and dogs | |
| AU769669B2 (en) | Method and composition to protect an obligate carnivore from a disease of abnormal carbohydrate metabolism | |
| US20080276877A1 (en) | Feed for fish and use thereof | |
| JP2012176949A (ja) | ビタミンｄ化合物の使用 | |
| US6245364B1 (en) | Weight reduction method for cats and other pets | |
| JPH05501798A (ja) | カルニチン補充の仕上げブタ飼料 | |
| KR100756572B1 (ko) | 소에 대한 생체이용가능한 메티오닌의 공급 방법 | |
| CN101426378B (zh) | 甘氨酸化合物在制备降低用于饲养家禽的饲料的转化率的家禽的非治疗性处理的药物中的用途 | |
| WO2010146155A1 (fr) | Suspension vétérinaire gélifiée de fer | |
| US5001143A (en) | Pharmaceutical composition for prophylactic and preventive of ketosis of livestocks | |
| JP3308541B2 (ja) | 魚用成長促進組成物及びその使用方法 | |
| Nabuurs et al. | Clinical signs and performance of pigs treated with different doses of carbadox, cyadox and olaquindox | |
| US4937077A (en) | Method for improving feed conversion of meat-producing animals by oral administration of 2-deoxy-D-hexose | |
| Cho et al. | D‐Methionine utilization in young miniature pigs, adult rabbits, and adult dogs | |
| KR20040047839A (ko) | 낙농 동물의 젖분비를 촉진하기 위한, 시스테아민을포함하는 조성물 | |
| EP1776956A1 (en) | Preventive and/or therapeutic agent for calcipenia | |
| Mendelson et al. | Puromycin inhibition of ethanol ingestion and liver alcohol dehydrogenase activity in the rat | |
| USRE39403E1 (en) | Method for supplying bioavailable methionine to a cow | |
| RU2580358C1 (ru) | Способ повышения продуктивности сельскохозяйственной птицы | |
| JPH11116478A (ja) | 肥満防止剤 | |
| CN106889317B (zh) | 一种幼龄反刍动物早期断奶促进剂及其饲喂方法 | |
| USRE38167E1 (en) | Weight reduction method for cats and other pets | |
| US6525095B1 (en) | Propionate feed supplement | |
| JPH027926B2 (https=) | ||
| JPH01320956A (ja) | 家蓄類の成長促進剤 |